CCTC - Certified Clinical Transplant Coordinator Long-Term Recipient Management Questions and Answers — Questions and Answers
Question 1: A 1-year post-kidney transplant recipient presents with a rising serum creatinine. A renal biopsy confirms BK virus nephropathy. What is the primary initial management strategy for this condition?
- Initiate a course of high-dose corticosteroids.
- Administer intravenous immunoglobulin (IVIG).
- Reduce the dosage of immunosuppressive medications. (Correct answer)
- Increase the dose of valganciclovir.
Correct answer: Reduce the dosage of immunosuppressive medications.
The cornerstone of management for BK virus nephropathy is the reduction of immunosuppression. This allows the patient's own immune system to clear the virus. This must be balanced carefully to avoid triggering an acute rejection episode. While other agents like IVIG or cidofovir may be used as adjunctive therapies, decreasing the immunosuppressive load is the first-line approach.
Question 2: Transplant recipients are at a significantly increased risk for developing certain malignancies due to long-term immunosuppression. Which of the following cancers has the highest incidence in the post-transplant population?
- Non-melanoma skin cancer (Correct answer)
- Colorectal cancer
- Post-transplant lymphoproliferative disorder (PTLD)
- Prostate cancer
Correct answer: Non-melanoma skin cancer
Long-term immunosuppression dramatically increases the risk for many cancers, with non-melanoma skin cancers (squamous cell and basal cell carcinoma) being the most common malignancy by a significant margin. While PTLD risk is also highly elevated compared to the general population, its absolute incidence is lower than that of skin cancers.
Question 3: A transplant coordinator is educating a recipient who has developed New-Onset Diabetes After Transplantation (NODAT). Which of the following immunosuppressive agents is most strongly associated with the development of this complication?
- Azathioprine
- Tacrolimus (Correct answer)
- Mycophenolate Mofetil
- Sirolimus
Correct answer: Tacrolimus
Calcineurin inhibitors, particularly tacrolimus, and corticosteroids are the immunosuppressive agents most strongly linked to the development of NODAT. Tacrolimus is known to be toxic to pancreatic islet cells and can induce insulin resistance. While sirolimus can also contribute, the association is strongest with tacrolimus.
Question 4: A 3-year post-heart transplant recipient, maintained on tacrolimus, presents for a routine visit with a new subtherapeutic trough level. The patient denies missing doses but recently started taking an over-the-counter herbal supplement. Which of the following is most likely responsible for the decreased tacrolimus level?
- St. John's Wort (Correct answer)
- Grapefruit juice
- Milk thistle
- Coenzyme Q10
Correct answer: St. John's Wort
St. John's Wort is a potent inducer of the cytochrome P450 3A4 (CYP3A4) enzyme system, which is the primary pathway for tacrolimus metabolism. By inducing this enzyme, St. John's Wort accelerates the breakdown of tacrolimus, leading to significantly lower, often subtherapeutic, blood levels and increasing the risk of rejection. In contrast, grapefruit juice is a CYP3A4 inhibitor and would increase levels.
Question 5: In lung transplant recipients, the most common manifestation of chronic allograft dysfunction is a progressive, irreversible airflow obstruction. What is the clinical term for this condition?
- Acute Cellular Rejection
- Bronchiolitis Obliterans Syndrome (BOS) (Correct answer)
- Restrictive Allograft Syndrome (RAS)
- Post-transplant Lymphoproliferative Disorder (PTLD)
Correct answer: Bronchiolitis Obliterans Syndrome (BOS)
Bronchiolitis Obliterans Syndrome (BOS) is the most common form of chronic lung allograft dysfunction (CLAD) and a leading cause of late graft failure. It is characterized by inflammation and fibrosis of the small airways, leading to a progressive and irreversible decline in expiratory airflow, measured by FEV1. RAS is a less common, restrictive form of CLAD.
Question 6: A 45-year-old female who received a kidney transplant two years ago expresses a desire to become pregnant. As the transplant coordinator, which of the following is the most critical piece of counseling to provide regarding her immunosuppressive regimen?
- She must stop all immunosuppressive medications during the first trimester.
- Mycophenolate mofetil (MMF) is a known teratogen and must be discontinued prior to conception. (Correct answer)
- Calcineurin inhibitors like tacrolimus are completely safe and require no dose adjustments during pregnancy.
- Pregnancy is absolutely contraindicated for all solid organ transplant recipients.
Correct answer: Mycophenolate mofetil (MMF) is a known teratogen and must be discontinued prior to conception.
Mycophenolate mofetil (MMF) and its active form, mycophenolic acid (MPA), are potent teratogens and are contraindicated in pregnancy. Exposure is associated with a high rate of first-trimester miscarriage and a specific pattern of birth defects. It is critical that MMF/MPA be stopped (ideally 6 weeks or more) before attempting conception and replaced with a safer alternative, such as azathioprine.
CCTC - Certified Clinical Transplant Coordinator Long-Term Recipient Management Questions and Answers
A 1-year post-kidney transplant recipient presents with a rising serum creatinine.
A renal biopsy confirms BK virus nephropathy.
What is the primary initial management strategy for this condition?